Thiopeptin is a new antibiotic, produced by Streptomyces tateyamensis and developed solely for animal use as a feed additive. The antibiotic content in animal tissue and feed was assayed in terms of the antimicrobial activity against Mycoplasma laidlawii A. This antibiotic was found to be relatively nontoxic in rats and mice. In chickens, this antibiotic is excreted into feces within 48 hr of administration and is not absorbed in tissue. It is well tolerated in both broilers and swine and is highly stable in animal feed. Thiopeptin-supplemented feed contributes to the improvement of weight gain, feed efficiency in chickens and swine, and the egg performance in layers. Thus, thiopeptin, when used as a feed additive, is quite suitable for supplementing animal nutrition.
Antibiotics incorporated into animal feed at low concentrations improve performance in livestock production. Antibiotics currently being used for this purpose are derived from human medicinals, and the tendency to increase the levels of supplementation has led to widespread speculation on the hazards to human or animal health. Antibiotics used in stockfeeds should differ from those of human medicinals and should not be absorbed into animal tissue. Thiopeptin is a new antibiotic produced by Streptomyces tateyamensis and may be readily used to supplement feed and thus improve performance in broilers, layers, and swine without resulting in any absorption. Its physicochemical and microbiological properties were reported in previous papers (5, 6) . The present paper concerns the toxicity, safety, tissue residue, stability, and efficacy of thiopeptin.
MATERIALS AND METHODS Antibiotic preparations. Thiopeptin used throughout the present studies had a purity greater than 80%; weight of thiopeptin used is expressed in terms In subacute toxicity tests in rats, no adverse effects were observed at the dose levels tested.
Safety trials in broilers and swine. None of the broilers receiving thiopeptin at 100 g/ton (100 times the use level) and none of those receiving lower doses showed any abnormal signs attributable to the medications. No pathological changes were noted in the birds fed thiopeptin at 100 g/ton.
Pigs raised on feed containing thiopeptin at 500 g/ton for 54 days showed neither toxic signs nor macroscopical changes at necropsy.
Tissue residue. As in Fig. 1 , a series of tests proved that thiopeptin, at a level as low as 0.03 jsg/ml, is assayable in Mycoplasma plates. The recovery percentage of thiopeptin in animal tissue is presented in Table 4 . The percentage ranged from 96 to 110%, with the exception of When a single dose of thiopeptin was given to broilers at 100 mg per bird, nearly 100% of thiopeptin was excreted into feces within 48 hr, and no trace of thiopeptin was detected in the major organs studied (Table 5) .
Thiopeptin was not recovered from the major organs of broilers that were used in the safety trials, and no trace of the antibiotic was noted in samples of major organs and subcutaneous fat from swine. When the entire contents of the gastrointestinal tract were removed, no thiopeptin was detected in the tissue.
Laying hens raised for 25 days on ration supplemented with 500 g of thiopeptin per ton produced eggs which contained no detectable amount of thiopeptin.
These results indicated that thiopeptin was not absorbed from the gastrointestinal tract and did not accumulate in tissue. The present bioassay methods can not detect metabolites of thiopeptin which may have no inhibitory activity against the growth of the test organisms. Although this Table 6 , thiopeptin feed was highly stable after storage at 30 C and 60% relative humidity for 3 months. The feed was similarly stable after storage at 121 C for 5 min; recovery of thiopeptin was 99.9% at 2.5 g/ton and 101.5% at 10.0 g/ton.
Efficacy trials. Figure 3 , which is summarized from Table 7 , shows the results of 17 trials in chickens. Some of the results were reported previously (1-3) . The effectiveness of mikamycin, manganese bacitracin, and chlortetracyclinehydrochloride is shown at the use levels for comparison. It is evident that, as the thiopeptin concentration was increased, weight gain became greater. Increasing the antibiotic concentration to more than 2 g/ton, however, did not result in substantial improvement. A summary of performance at use levels of thiopeptin in feed (1 and 2 g/ton) is shown in Table 8 .
Thiopeptin improved performance in laying hens (Table 9 ). Feeding of thiopeptin for 150 days at the level of 0.625 g/ton resulted in greater total egg weight than that in the control group (P < 0.05). This difference was related to the greater number of eggs produced by hens on thiopeptin ration than by control hens. There was no difference in weight of eggs between the two groups. No attempt was made to test hatchability of these eggs, owing to the fact that roosters were not used in the trial.
Pigs raised on feed supplemented with thiopeptin at 1 g/ton of ration required an average of 124 days to reach 90 kg of body weight, whereas pigs fed nonmedicated ration required 8 additional days to reach the same weight. Although the number of pigs was insufficient to permit statistical analysis, feeding with thiopeptin improved performance by 4.8% over nonmedicated controls (Table 10) .
The results confirm that thiopeptin, an antibiotic for animal use only, is a suitable feed additive for improving the performance in broilers, layers, and swine.
LITERATURE CITED
